NCT07078370 - Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

March 31, 2027

Conditions

Coronary Artery DiseaseMulti Vessel Coronary Artery Disease

Interventions

DEVICE

ATEV with ESS

Patients will be implanted with a single Acellular Tissue Engineered Vessel with External Support Structure bypass (single proximal and distal anastomoses) to the second or third coronary artery bypass target

Trial Locations (2)

Unknown

University Clinical Hospital No. 2 PUM in Szczecin, Szczecin

Medicover, Warsaw